M. Gonschorowsky, K. Merz, M. Driess
FULL PAPER
3
2
26.4 (d, JP,C = 10.6 Hz, C3-, C5-Cy), 29.2 (d, JP,C = 12.0 Hz, C2-, Preparation of CyP(S)(CH2OH)2 (4): Elemental sulfur (86 mg,
1
1
C6-Cy), 29.4 (d, JP,C = 13.8 Hz, C1-Cy), 57.3 (d, JP,C = 10.4 Hz,
PCH2) ppm. 31P NMR (101.25 MHz, D2O): δ = –11.4 (br. s) ppm.
EI-MS: m/z (%) = 176 [M+ (19)], 146 [M+ – CH2O (18)], 115
2.670 mmol) was added to a solution of phosphane 1 (470 mg,
2.670 mmol) in 10 mL toluene at room temperature. While stirring
for 30 min the sulfur disappeared and a colorless solid was formed.
After evaporation of the solvent the residue was re-dissolved in
ethanol (8 mL) and filtered. The solvent was again partly removed
in vacuo and diethyl ether was added causing the product to pre-
cipitate. The solid was filtered off and dried in vacuo yielding 4
as a colorless crystalline solid. Yield: 555 mg (100%). C8H17O2SP
(208.2): calcd. C 46.15, H 8.23; found C 45.9, H 8.15. 1H NMR
(250.13 MHz, D2O): δ = 1.10–1.81 (m, 11 H, Cy), 4.18 (m, 4 H,
PCH2) ppm. 13C NMR (62.90 MHz, D2O): δ = 25.1 (s, C-4 Cy),
+
+
[CyPH+ (17)], 83 [Cy+ (70)], 55 [C4H7 (100)] 41 [C3H5 (74)].
Preparation of CyP[CH2N(H)CH2COOH]2 (2): A solution of gly-
cine (0.83 g, 11.38 mmol) in degassed water (3.5 mL) was added via
a syringe to phosphane 1 (0.57 g, 3.24 mmol) in 1.5 mL oxygen-
free ethanol and stirred overnight at 25 °C. The formed solid was
filtered off and the filtrate evaporated giving the product as a color-
less crystalline solid. Yield: 808 mg (86%). 1H NMR (250.13 MHz,
DCl/D2O): δ = –0.92 to –0.80 (m, 5 H, Cy), –0.31 to –0.05 (m, 6
3
2
25.5 (d, JP,C = 3.8 Hz, C3-, C5-Cy), 26.5 (d, JP,C = 16.7 Hz, C-
2
2
H, Cy), 1.61 (br. d, JH,H = 14.1 Hz, 2 H, PCH2), 1.76 (dd, JP,H
1
1
2,C-6 Cy), 32.8 (d, JP,C = 52.3 Hz, C-1Cy), 58.1 (d, JP,C
=
= 2.2, 2JH,H = 14.1 Hz, 2 H, PCH2), 2.16 (d, 2JH,H = 17.2 Hz, 2 H,
66.7 Hz, PCH2) ppm. 31P NMR (101.25 MHz, D2O): δ = 54.5 (s)
ppm. EI-MS: m/z (%) = 208 [M+ (69)], 178 [M+-CH2O (9)], 127
[M+ – Cy + H (47)], 126 [M+ – Cy + 2 H (38)], 108 [M+ – Cy –
2
CH2COOH), 2.20 (d, JH,H = 17.2 Hz, 2 H, CH2COOH) ppm. 13
C
3
NMR (62.90 MHz, DCl/D2O): δ = 24.9 (s, C-4-Cy), 25.9 (d, JP,C
2
= 11.3 Hz C-3-, C-5-Cy), 27.8 (d, JP,C = 10.8 Hz, C-2-,C-6-Cy),
OH (100)], 83 [Cy+ (39)], 78 [HP(S)CH2 (84)], 55 [C4H7+ (82)], 41
+
1
1
32.8 (d, JP,C = 4.6 Hz, C-1-Cy), 43.6 (d, JP,C = 18.8 Hz, PCH2),
+
[C3H5 (70)].
3
48.4 (d, JP,C = 7.6 Hz, CH2COOH), 168.0 (s, COOH) ppm. 31P
NMR (101.25 MHz, DCl/D2O): δ = –24.4 (br. s) ppm. ESI-MS
Preparation of cis-[PtCl2{CyP(CH2OH)2}2] (5): Phosphane
1
(negative mode): 289.3 [M – H+].
(218 mg, 1.236 mmol) and Pt(COD)Cl2 (231 mg, 0.618 mmol) were
dissolved in CH2Cl2 (10 mL) and stirred for 2 h at room tempera-
ture. After standing for another 4 h at 25 °C the formed solid was
filtered off and dried in vacuo giving the product as a colorless
crystalline solid, which may be recrystallized from hot methanol.
Yield: 313 mg (82%). C16H34Cl2O4P2Pt (618.4): calcd. C 31.1, H
5.5; found C 31.2, H 5.8. 1H NMR (250.13 MHz, [D4]MeOH): δ =
1.21 –1.79 (m, 12 H, Cy-H3,–H4,–H5), 1.83 (br. m, 4 H, Cy-H2,-
Preparation of CyP(O)(CH2OH)2 (3): Aqueous hydrogen peroxide
(0.3%, 6 mL) was added to a solution of compound 1 (100 mg,
0.568 mmol) in 20 mL methanol and stirred in air for 10 min. The
solvent was removed at a rotor vapour, co-evaporated twice with
water (2×10 mL) and washed with dry ether (10 mL). After drying
in vacuo the product 3 was obtained as colorless crystalline solid.
Yield: 87 mg (81%). C8H17O3P (192.2): calcd. C 50.0, H 8.9; found
1
C 50.4, H 9.3. H NMR (250.13 MHz, D2O): δ = 1.10–1.41 (m, 4 H6), 2.21 (br. m, 4 H, Cy-H2,-H6), 2.58 (br. m, 2 H, Cy-H1), 4.43
2
2
3
H, Cy), 1.58 –1.85 (m, 6 H, Cy) 1.98 (m, 1 H, H1–Cy) 4.02 (m, 4 (m, JH,H = 14.0, JP,H = 0.8, JPt,H = 18.6 Hz, 4 H, PCH2), 4.67
4
2
2
3
H, PCH2) ppm. 13C NMR (62.90 MHz, D2O): δ = 24.4 (d, JP,C
=
(m, JH,H = 14.0, JP,H = 2.0, JPt,H = 29.4 Hz, 4 H, PCH2) ppm.
3
2
1 Hz, C-4-Cy), 25.7 (d, JP,C = 3.4 Hz, C3-, C-5-Cy), 25.9 (d, JP,C
13C NMR (62.90 MHz, [D4]MeOH): δ = 26.2 (br. s, C-4 Cy), 27.2/
1
3
= 12.7 Hz, C-2,C-6-Cy), 32.2 (d, JP,C = 61.8 Hz, C-1 Cy), 54.8 (d, 27.4 (d, JP,C = 6.0 Hz, C-3, C-5 Cy), 29.8 (br. s, C2-,C6-Cy), 36.0
1JP,C = 75.6 Hz, PCH2) ppm. 31P NMR (101.25 MHz, D2O): δ =
(m, C-1 Cy), 54.8 (m, PCH2) ppm. 31P NMR (101.25 MHz, [D4]-
1
55.7 (br. s) ppm. ESI-MS (negative mode): 191.3 [M – H+].
MeOH): δ = 15.8 [s; Pt-satellites (d), JPt,P = 3490 Hz] ppm.
Table 5. Crystallographic data for compounds 1, 3, 4 and 6.
1
3
4
6
Empirical formula
Formula mass
Crystal system
Space group
C8H17O2P
179.19
monoclinic
C2/c
C8H17O3P
192.19
monoclinic
P21/c
C8H17O2PS
208.25
monoclinic
P21/c
C8H17Cu2I2O8P4
1085.62
monoclinic
P21/n
Cell constants
a [Å]
b [Å]
c [Å]
34.28(2)
5.161(4)
22.210(5)
110.21(2)
3687(5)
6.613(3)
15.882(5)
6.4485(16)
11.102(3)
108.740(5)
1076.7(5)
4
9.48(2)
17.39(3)
13.99(2)
107.81(8)
2196(7)
31.132(16)
5.4195(19)
114.014(14)
1019.2(8)
β [°]
Volume [Å3]
Z
16
4
2
Density (calculated) [Mg·m–3]
Absorption coefficient [mm–1]
Crystal size [mm]
Theta range for data collection
Reflections collected
Independent reflections
Goodness-of-fit on F2
R indices [I Ͼ 2σ(I)]
1.269
0.251
0.3 x0.2×0.2
1.93 to 22.50
2644
1974 (Rint = 0.1165)
1.069
R1 = 0.1167,
wR2 = 0.2390
R1 = 0.2223,
wR2 = 0.2664
0.474/–0.448
1.252
0.239
0.3×0.2×0.1
2.62 to 25.01
3799
1486 (Rint = 0.0879)
1.033
R1 = 0.0790,
wR2 = 0.1874
R1 = 0.1250,
wR2 = 0.2142
0.443/–0.518
1.285
0.412
0.2×0.1×0.1
2.71 to 30.01
5351
2730 (Rint = 0.0309)
1.028
R1 = 0.0452,
wR2 = 0.1061
R1 = 0.0672,
wR2 = 0.1140
0.438/–0.305
1.642
2.562
0.3×0.2×0.2
2.31 to 25.07
7412
3572 (Rint = 0.0337)
1.028
R1 = 0.0468,
wR2 = 0.1194
R1 = 0.0616,
wR2 = 0.1302
2.456/–0.850
R indices (all data)
Largest diff. peak/hole [e·Å–3]
462
www.eurjic.org
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2006, 455–463